Anew Labs

ByteDance spins off AI drug unit that raises $290M

ByteDance has completed a $290 million fundraising for Anew Labs, its newly spun-off AI drug discovery unit headquartered in Shanghai, valuing the business at $1.5 billion in its first external funding round, Reuters reported on Wednesday, citing two people with…